{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:22:49Z","timestamp":1793726569793,"version":"4.6.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00125-018-4626-y","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T13:34:52Z","timestamp":1525181692000},"page":"1592-1602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificates"],"prefix":"10.1007","volume":"61","author":[{"given":"Francesco","family":"Zaccardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafeesa N.","family":"Dhalwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,1]]},"reference":[{"key":"4626_CR1","unstructured":"World Health Organization (2016). Global report on diabetes 2016. Available from \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/204871\/1\/9789241565257_eng.pdf\n                    \n                  . Accessed 23 May 2017"},{"key":"4626_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"SR Seshasai","year":"2011","unstructured":"Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829\u2013841","journal-title":"N Engl J Med"},{"key":"4626_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","volume":"92","author":"F Zaccardi","year":"2016","unstructured":"Zaccardi F, Webb DR, Yates T, Davies MJ (2016) Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J 92:63\u201369","journal-title":"Postgrad Med J"},{"key":"4626_CR4","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(14)60794-7","volume":"383","author":"RR Holman","year":"2014","unstructured":"Holman RR, Sourij H, Califf RM (2014) Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes. Lancet 383:2008\u20132017","journal-title":"Lancet"},{"key":"4626_CR5","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.2337\/db14-0059","volume":"63","author":"PE Cryer","year":"2014","unstructured":"Cryer PE (2014) Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia. Diabetes 63:2188\u20132195","journal-title":"Diabetes"},{"key":"4626_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1464-5491.2011.03416.x","volume":"29","author":"S Barendse","year":"2012","unstructured":"Barendse S, Singh H, Frier BM, Speight J (2012) The impact of hypoglycaemia on quality of life and related patient-reported outcomes in type 2 diabetes: a narrative review. Diabet Med 29:293\u2013302","journal-title":"Diabet Med"},{"key":"4626_CR7","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00125-015-3646-0","volume":"58","author":"F Zaccardi","year":"2015","unstructured":"Zaccardi F, Webb DR, Kurl S, Khunti K, Davies MJ, Laukkanen JA (2015) Inverse association between fasting plasma glucose and risk of ventricular arrhythmias. Diabetologia 58:1797\u20131802","journal-title":"Diabetologia"},{"key":"4626_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2337\/db16-1310","volume":"66","author":"E Chow","year":"2017","unstructured":"Chow E, Bernjak A, Walkinshaw E et al (2017) Cardiac autonomic regulation and repolarization during acute experimental hypoglycemia in type 2 diabetes. Diabetes 66:1322\u20131333","journal-title":"Diabetes"},{"key":"4626_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2337\/dc16-2177","volume":"40","author":"P Novodvorsky","year":"2017","unstructured":"Novodvorsky P, Bernjak A, Chow E et al (2017) Diurnal differences in risk of cardiac arrhythmias during spontaneous hypoglycemia in young people with type 1 diabetes. Diabetes Care 40:655\u2013662","journal-title":"Diabetes Care"},{"key":"4626_CR10","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.2337\/db13-0468","volume":"63","author":"E Chow","year":"2014","unstructured":"Chow E, Bernjak A, Williams S et al (2014) Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes 63:1738\u20131747","journal-title":"Diabetes"},{"key":"4626_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/jamainternmed.2013.12956","volume":"174","author":"ES Huang","year":"2014","unstructured":"Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ (2014) Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med 174:251\u2013258","journal-title":"JAMA Intern Med"},{"key":"4626_CR12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMra1215228","volume":"369","author":"PE Cryer","year":"2013","unstructured":"Cryer PE (2013) Mechanisms of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 369:362\u2013372","journal-title":"N Engl J Med"},{"key":"4626_CR13","first-page":"1341","volume":"78","author":"GS Meneilly","year":"1994","unstructured":"Meneilly GS, Cheung E, Tuokko H (1994) Altered responses to hypoglycemia of healthy elderly people. J Clin Endocrinol Metab 78:1341\u20131348","journal-title":"J Clin Endocrinol Metab"},{"key":"4626_CR14","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1001\/jamainternmed.2014.1824","volume":"174","author":"KJ Lipska","year":"2014","unstructured":"Lipska KJ, Ross JS, Wang Y et al (2014) National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med 174:1116\u20131124","journal-title":"JAMA Intern Med"},{"key":"4626_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2337\/dc16-0985","volume":"40","author":"KJ Lipska","year":"2017","unstructured":"Lipska KJ, Yao X, Herrin J et al (2017) Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006-2013. Diabetes Care 40:468\u2013475","journal-title":"Diabetes Care"},{"key":"4626_CR16","doi-asserted-by":"publisher","first-page":"e0137596","DOI":"10.1371\/journal.pone.0137596","volume":"10","author":"KK Clemens","year":"2015","unstructured":"Clemens KK, Shariff S, Liu K et al (2015) Trends in antihyperglycemic medication prescriptions and hypoglycemia in older adults: 2002-2013. PLoS One 10:e0137596","journal-title":"PLoS One"},{"key":"4626_CR17","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S2213-8587(16)30091-2","volume":"4","author":"F Zaccardi","year":"2016","unstructured":"Zaccardi F, Davies MJ, Dhalwani NN et al (2016) Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study. Lancet Diabetes Endocrinol 4:677\u2013685","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4626_CR18","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1097\/MD.0000000000001029","volume":"94","author":"A Sako","year":"2015","unstructured":"Sako A, Yasunaga H, Matsui H et al (2015) Hospitalization for hypoglycemia in Japanese diabetic patients: a retrospective study using a national inpatient database, 2008-2012. Medicine (Baltimore) 94:e1029","journal-title":"Medicine (Baltimore)"},{"key":"4626_CR19","unstructured":"Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, Inoue M (2001) Age standardization of rates: a new WHO standard. Available from \n                    http:\/\/who.int\/healthinfo\/paper31.pdf\n                    \n                  . Accessed 9 Feb 2017"},{"key":"4626_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00038-008-7068-3","volume":"53","author":"CO Schmidt","year":"2008","unstructured":"Schmidt CO, Kohlmann T (2008) When to use the odds ratio or the relative risk? Int J Public Health 53:165\u2013167","journal-title":"Int J Public Health"},{"key":"4626_CR21","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/archinte.1997.00440360095010","volume":"157","author":"RI Shorr","year":"1997","unstructured":"Shorr RI, Ray WA, Daugherty JR, Griffin MR (1997) Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 157:1681\u20131686","journal-title":"Arch Intern Med"},{"key":"4626_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2337\/dc07-1790","volume":"31","author":"AA Ginde","year":"2008","unstructured":"Ginde AA, Espinola JA, Camargo CA Jr (2008) Trends and disparities in U.S. emergency department visits for hypoglycemia, 1993-2005. Diabetes Care 31:511\u2013513","journal-title":"Diabetes Care"},{"key":"4626_CR23","doi-asserted-by":"publisher","first-page":"b5444","DOI":"10.1136\/bmj.b5444","volume":"340","author":"ME Miller","year":"2010","unstructured":"Miller ME, Bonds DE, Gerstein HC et al (2010) The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 340:b5444","journal-title":"BMJ"},{"key":"4626_CR24","doi-asserted-by":"crossref","unstructured":"Karter AJ, Lipska KJ, PJ O' Connor et al (2017) High rates of severe hypoglycemia among African American patients with diabetes: the surveillance, prevention, and management of diabetes mellitus (SUPREME-DM) network. J Diabetes Complicat 31:869\u2013873","DOI":"10.1016\/j.jdiacomp.2017.02.009"},{"key":"4626_CR25","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1111\/dom.12941","volume":"19","author":"F Zaccardi","year":"2017","unstructured":"Zaccardi F, Webb DR, Davies MJ et al (2017) Risk factors and outcome differences in hypoglycaemia-related hospital admissions: a case-control study in England. Diabetes Obes Metab 19:1371\u20131378","journal-title":"Diabetes Obes Metab"},{"key":"4626_CR26","unstructured":"Institute for Health Metrics and Evaluation (2015) Global Burden of Disease Study 2015 (GBD 2015) Socio-Demographic Index (SDI) 1980\u20132015. Available from \n                    http:\/\/ghdx.healthdata.org\/record\/global-burden-disease-study-2015-gbd-2015-socio-demographic-index-sdi-1980%E2%80%932015\n                    \n                  . Accessed 7 Apr 2017"},{"key":"4626_CR27","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/dom.12849","volume":"19","author":"ZZ Htike","year":"2017","unstructured":"Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ (2017) Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a systematic review and mixed-treatment comparison analysis. Diabetes Obes Metab 19:524\u2013536","journal-title":"Diabetes Obes Metab"},{"key":"4626_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.beem.2016.06.002","volume":"30","author":"S Chatterjee","year":"2016","unstructured":"Chatterjee S, Khunti K, Davies MJ (2016) Optimizing management of glycaemia. Best Pract Res Clin Endocrinol Metab 30:397\u2013411","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"4626_CR29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/dom.12670","volume":"18","author":"F Zaccardi","year":"2016","unstructured":"Zaccardi F, Webb DR, Htike ZZ, Youssef D, Khunti K, Davies MJ (2016) Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis. Diabetes Obes Metab 18:783\u2013794","journal-title":"Diabetes Obes Metab"},{"key":"4626_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.7326\/M15-1432","volume":"164","author":"F Zaccardi","year":"2016","unstructured":"Zaccardi F, Htike ZZ, Webb DR, Khunti K, Davies MJ (2016) Benefits and harms of once-weekly glucagon-like peptide-1 receptor agonist treatments: a systematic review and network meta-analysis. Ann Intern Med 164:102\u2013113","journal-title":"Ann Intern Med"},{"key":"4626_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/dom.12689","volume":"18","author":"K Khunti","year":"2016","unstructured":"Khunti K, Alsifri S, Aronson R et al (2016) Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab 18:907\u2013915","journal-title":"Diabetes Obes Metab"},{"key":"4626_CR32","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1001\/jama.2016.0299","volume":"315","author":"KJ Lipska","year":"2016","unstructured":"Lipska KJ, Krumholz H, Soones T, Lee SJ (2016) Polypharmacy in the aging patient: a review of glycemic control in older adults with type 2 diabetes. JAMA 315:1034\u20131045","journal-title":"JAMA"},{"key":"4626_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/jamainternmed.2014.7345","volume":"175","author":"KJ Lipska","year":"2015","unstructured":"Lipska KJ, Ross JS, Miao Y, Shah ND, Lee SJ, Steinman MA (2015) Potential overtreatment of diabetes mellitus in older adults with tight glycemic control. JAMA Intern Med 175:356\u2013362","journal-title":"JAMA Intern Med"},{"key":"4626_CR34","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jamainternmed.2016.2275","volume":"176","author":"RG McCoy","year":"2016","unstructured":"McCoy RG, Lipska KJ, Yao X, Ross JS, Montori VM, Shah ND (2016) Intensive treatment and severe hypoglycemia among adults with type 2 diabetes. JAMA Intern Med 176:969\u2013978","journal-title":"JAMA Intern Med"},{"key":"4626_CR35","doi-asserted-by":"publisher","first-page":"e106072","DOI":"10.1371\/journal.pone.0106072","volume":"9","author":"YT Bazargani","year":"2014","unstructured":"Bazargani YT, de Boer A, Leufkens HG, Mantel-Teeuwisse AK (2014) Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists. PLoS One 9:e106072","journal-title":"PLoS One"},{"key":"4626_CR36","unstructured":"World Health Organization (2013) The selection and use of essential medicines. Report of the WHO Expert Committee, 2013 (including the 18th WHO Model List of Essential Medicines and the 4th WHO Model List of Essential Medicines for Children) Available from \n                    http:\/\/apps.who.int\/iris\/bitstream\/10665\/112729\/1\/WHO_TRS_985_eng.pdf\n                    \n                  . Accessed 23 June 2017"},{"key":"4626_CR37","unstructured":"International Diabetes Federation (2016) Access to medicines and supplies for people with diabetes. Available from \n                    www.idf.org\/accesstomedicine\n                    \n                  . Accessed 23 June 2017"},{"key":"4626_CR38","unstructured":"Institute for Health Metrics and Evaluation. Global Burden of Disease (GBD) (2018). Available from \n                    www.healthdata.org\/gbd\n                    \n                  . Accessed on 7 Apr 2017"},{"key":"4626_CR39","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1478-7954-12-14","volume":"12","author":"DE Phillips","year":"2014","unstructured":"Phillips DE, Lozano R, Naghavi M et al (2014) A composite metric for assessing data on mortality and causes of death: the vital statistics performance index. Popul Health Metrics 12:14","journal-title":"Popul Health Metrics"},{"key":"4626_CR40","unstructured":"World Health Organization (2010) International Statistical Classification of Diseases and Related Health Problems: 10th Revision. Available from \n                    www.who.int\/classifications\/icd\/ICD10Volume2_en_2010.pdf?ua=1\n                    \n                  . Accessed 23 Feb 2018"},{"key":"4626_CR41","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2337\/diacare.29.02.06.dc05-0998","volume":"29","author":"LN McEwen","year":"2006","unstructured":"McEwen LN, Kim C, Haan M et al (2006) Diabetes reporting as a cause of death: results from the Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care 29:247\u2013253","journal-title":"Diabetes Care"},{"key":"4626_CR42","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2337\/dc10-2312","volume":"34","author":"LN McEwen","year":"2011","unstructured":"McEwen LN, Karter AJ, Curb JD, Marrero DG, Crosson JC, Herman WH (2011) Temporal trends in recording of diabetes on death certificates: results from Translating Research Into Action for Diabetes (TRIAD). Diabetes Care 34:1529\u20131533","journal-title":"Diabetes Care"},{"key":"4626_CR43","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1093\/aje\/kwq057","volume":"171","author":"TH Lu","year":"2010","unstructured":"Lu TH, Anderson RN, Kawachi I (2010) Trends in frequency of reporting improper diabetes-related cause-of-death statements on death certificates, 1985-2005: An algorithm to identify incorrect causal sequences. Am J Epidemiol 171:1069\u20131078","journal-title":"Am J Epidemiol"},{"key":"4626_CR44","doi-asserted-by":"crossref","unstructured":"Lu TH, Walker S, Johansson LA, Huang CN (2005) An international comparison study indicated physicians\u2019 habits in reporting diabetes in part I of death certificate affected reported national diabetes mortality. J Clin Epidemiol 58:1150\u20131157","DOI":"10.1016\/j.jclinepi.2005.03.009"},{"key":"4626_CR45","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1007\/s00125-006-0470-6","volume":"49","author":"TH Lu","year":"2006","unstructured":"Lu TH, Hsu PY, Bjorkenstam C, Anderson RN (2006) Certifying diabetes-related cause-of-death: a comparison of inappropriate certification statements in Sweden, Taiwan and the USA. Diabetologia 49:2878\u20132881","journal-title":"Diabetologia"},{"key":"4626_CR46","first-page":"117","volume":"385","author":"GBD","year":"2013","unstructured":"GBD (2013) Mortality and Causes of Death Collaborators (2015) Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385:117\u2013171","journal-title":"Lancet"},{"key":"4626_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12889-015-1591-y","volume":"15","author":"PA Diaz-Valencia","year":"2015","unstructured":"Diaz-Valencia PA, Bougneres P, Valleron AJ (2015) Global epidemiology of type 1 diabetes in young adults and adults: a systematic review. BMC Public Health 15:255","journal-title":"BMC Public Health"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-018-4626-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4626-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-018-4626-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T20:09:41Z","timestamp":1556654981000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-018-4626-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,1]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["4626"],"URL":"https:\/\/doi.org\/10.1007\/s00125-018-4626-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,1]]},"assertion":[{"value":"16 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KK has acted as a consultant and speaker for Novartis, Novo Nordisk, Sanofi-Aventis, Lilly and Merck Sharp & Dohme. He has received grants in support of investigator and investigator-initiated trials from Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Pfizer, Boehringer Ingelheim and Merck Sharp & Dohme. MJD has acted as consultant, advisory board member and speaker for Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Boehringer Ingelheim, AstraZeneca and Janssen and as a speaker for Mitsubishi Tanabe Pharma Corporation. She has received grants in support of investigator and investigator-initiated trials from Novo Nordisk, Sanofi-Aventis and Lilly. DRW has received grants in support of investigator-initiated studies and honoraria from Sanofi-Aventis and Novo Nordisk. All other authors declare that there is no duality of interest associated with their contribution to this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Duality of interest"}}]}}